Clovis Oncology, Inc. Insider Trading for March 2018
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Clovis Oncology, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Clovis Oncology, Inc. for March 2018.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 21 2018 | CLVS | Clovis Oncology, I ... | Rolfe Lindsey | See Remarks | Option Exercise | M | 0.00 | 3,437 | 0 | 37,813 | |
| Mar 21 2018 | CLVS | Clovis Oncology, I ... | Rolfe Lindsey | See Remarks | Payment of Exercise | F | 56.75 | 1,728 | 98,064 | 9,789 | 11.5 K to 9.8 K (-15.00 %) |
| Mar 21 2018 | CLVS | Clovis Oncology, I ... | Rolfe Lindsey | See Remarks | Buy | M | 0.00 | 3,437 | 0 | 11,517 | 8.1 K to 11.5 K (+42.54 %) |
| Mar 21 2018 | CLVS | Clovis Oncology, I ... | IVERS-READ GILLIAN C | See Remarks | Option Exercise | M | 0.00 | 1,875 | 0 | 20,625 | |
| Mar 21 2018 | CLVS | Clovis Oncology, I ... | IVERS-READ GILLIAN C | See Remarks | Payment of Exercise | F | 56.75 | 829 | 47,046 | 182,995 | 183.8 K to 183 K (-0.45 %) |
| Mar 21 2018 | CLVS | Clovis Oncology, I ... | IVERS-READ GILLIAN C | See Remarks | Buy | M | 0.00 | 1,875 | 0 | 183,824 | 181.9 K to 183.8 K (+1.03 %) |
| Mar 09 2018 | CLVS | Clovis Oncology, I ... | SPICKSCHEN THORLEF | Director | Sell | S | 61.47 | 4,500 | 276,615 | 12,118 | 16.6 K to 12.1 K (-27.08 %) |
| Mar 09 2018 | CLVS | Clovis Oncology, I ... | MUEHL DANIEL W | See Remarks | Option Exercise | M | 0.00 | 1,875 | 0 | 5,625 | |
| Mar 09 2018 | CLVS | Clovis Oncology, I ... | MUEHL DANIEL W | See Remarks | Payment of Exercise | F | 58.43 | 826 | 48,263 | 3,953 | 4.8 K to 4 K (-17.28 %) |
| Mar 09 2018 | CLVS | Clovis Oncology, I ... | MUEHL DANIEL W | See Remarks | Buy | M | 0.00 | 1,875 | 0 | 4,779 | 2.9 K to 4.8 K (+64.57 %) |
| Mar 09 2018 | CLVS | Clovis Oncology, I ... | Hooks Corwin Dale | See Remarks | Option Exercise | M | 0.00 | 1,875 | 0 | 5,625 | |
| Mar 09 2018 | CLVS | Clovis Oncology, I ... | Hooks Corwin Dale | See Remarks | Payment of Exercise | F | 58.43 | 938 | 54,807 | 4,026 | 5 K to 4 K (-18.90 %) |
| Mar 09 2018 | CLVS | Clovis Oncology, I ... | Hooks Corwin Dale | See Remarks | Buy | M | 0.00 | 1,875 | 0 | 4,964 | 3.1 K to 5 K (+60.70 %) |
| Mar 09 2018 | CLVS | Clovis Oncology, I ... | Rolfe Lindsey | See Remarks | Option Exercise | M | 0.00 | 2,500 | 0 | 7,500 | |
| Mar 09 2018 | CLVS | Clovis Oncology, I ... | Rolfe Lindsey | See Remarks | Payment of Exercise | F | 58.43 | 1,260 | 73,622 | 8,080 | 9.3 K to 8.1 K (-13.49 %) |
| Mar 09 2018 | CLVS | Clovis Oncology, I ... | Rolfe Lindsey | See Remarks | Buy | M | 0.00 | 2,500 | 0 | 9,340 | 6.8 K to 9.3 K (+36.55 %) |
| Mar 07 2018 | CLVS | Clovis Oncology, I ... | IVERS-READ GILLIAN C | See Remarks | Option Exercise | M | 0.00 | 2,500 | 0 | 7,500 | |
| Mar 07 2018 | CLVS | Clovis Oncology, I ... | IVERS-READ GILLIAN C | See Remarks | Payment of Exercise | F | 58.43 | 1,122 | 65,558 | 181,949 | 183.1 K to 181.9 K (-0.61 %) |
| Mar 07 2018 | CLVS | Clovis Oncology, I ... | IVERS-READ GILLIAN C | See Remarks | Buy | M | 0.00 | 2,500 | 0 | 183,071 | 180.6 K to 183.1 K (+1.38 %) |
| Mar 02 2018 | CLVS | Clovis Oncology, I ... | Hooks Corwin Dale | See Remarks | Option Exercise | A | 0.00 | 9,000 | 0 | 9,000 | |
| Mar 02 2018 | CLVS | Clovis Oncology, I ... | Hooks Corwin Dale | See Remarks | Option Exercise | A | 58.43 | 9,000 | 525,870 | 9,000 | |
| Mar 02 2018 | CLVS | Clovis Oncology, I ... | MUEHL DANIEL W | See Remarks | Option Exercise | A | 0.00 | 9,000 | 0 | 9,000 | |
| Mar 02 2018 | CLVS | Clovis Oncology, I ... | MUEHL DANIEL W | See Remarks | Option Exercise | A | 58.43 | 9,000 | 525,870 | 9,000 | |
| Mar 02 2018 | CLVS | Clovis Oncology, I ... | IVERS-READ GILLIAN C | See Remarks | Option Exercise | A | 0.00 | 11,000 | 0 | 11,000 | |
| Mar 02 2018 | CLVS | Clovis Oncology, I ... | IVERS-READ GILLIAN C | See Remarks | Option Exercise | A | 58.43 | 11,000 | 642,730 | 11,000 | |
| Mar 02 2018 | CLVS | Clovis Oncology, I ... | MAHAFFY PATRICK J | See Remarks | Option Exercise | A | 58.43 | 120,000 | 7,011,600 | 120,000 | |
| Mar 02 2018 | CLVS | Clovis Oncology, I ... | Rolfe Lindsey | See Remarks | Option Exercise | A | 0.00 | 11,000 | 0 | 11,000 | |
| Mar 02 2018 | CLVS | Clovis Oncology, I ... | Rolfe Lindsey | See Remarks | Option Exercise | A | 58.43 | 11,000 | 642,730 | 11,000 |